Sc
Non verificato

Scholar Rock

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieMercato azionarioSalute
29/04/2026
Eventi
Attrezzature medico-sanitarie
Igiene alimentare
Biotecnologia
Medicina - Varie
Sanità
Salute
Oncologia
Scholar Rock to Present at the BofA Securities 2026 Health Care Conference
1.00
17/04/2026
Finanza
Biotecnologia
Farmaceutica
Salute
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1.00
16/04/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026
1.00
31/03/2026
Industria
Attrezzature medico-sanitarie
Salute
Igiene alimentare
Biotecnologia
Medicina - Varie
Farmaceutica
Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)
1.00
13/03/2026
Mercato azionario
Finanza
Biotecnologia
Farmaceutica
Salute
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1.00
03/03/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
Biotecnologia
Scienza
Farmaceutica
CORRECTING and REPLACING Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
1.00
03/03/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
Biotecnologia
Scienza
Farmaceutica
Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
1.00
18/02/2026
Attrezzature medico-sanitarie
Igiene alimentare
Salute
Biotecnologia
Medicina - Varie
Eventi
Scholar Rock to Present at Upcoming Investor Conferences
1.00
13/02/2026
Biotecnologia
Farmaceutica
Salute
Finanza
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1.00
10/02/2026
Biotecnologia
Farmaceutica
Salute
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0